Saturday, July 4, 2026 Live from SEC EDGAR

The Wire Leaderboards Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

ABVX — Abivax S.A. SEC Filings | FilingIndex

ABVXNasdaq

Abivax S.A.

Pharmaceutical Preparations · I0 · CIK 1956827

Abivax develops and commercializes innovative antiviral and anti-inflammatory drugs

+ Watch View on EDGAR ↗

$11.54B

Market cap

$144.65

Last close

+9.1%

1D

+56.6%

5D

4.0M

Volume

Price$144.65+1764.0%· 1Y

Jul 2L $7.75 · H $145.31Jul 2

49

Total filings

Jul 2, 2026

Last filing

12/31

Fiscal year end

All 6-K · 35 424B5 · 4 SC 13G · 3 20-F · 3 SC 13D/A · 2 SC 13D · 1 424B4 · 1

424B5424B5Jul 2, 2026 424B5424B5Jun 30, 2026 424B5424B5Jul 24, 2025 424B5424B5Jul 23, 2025

Similar companies

Comparable business profile · signals at a glance

SNYSanofi$103.3B+3.7%BUDAnheuser-Busch InBev SA/NV$157.2B+1.4%SAPSAP SE$189.8B+2.2%TAKTAKEDA PHARMACEUTICAL CO LTD$53.0B+5.1%MTArcelorMittal$48.0B

+7.0%

TVGRUPO TELEVISA, S.A.B.$1.4B-1.5%